A Package Insert Leaflet (PIL) is the approved product information provided with a medicine, describing indications, dosing, contraindications, warnings, and adverse reactions.
In research settings, PIL content can inform protocol safety sections, concomitant medication restrictions, and expected adverse event profiles for background therapies. PILs also support participant education when a marketed product is used as standard-of-care or comparator therapy. Accurate use helps ensure consistency between study procedures and established clinical guidance. Clear referencing strengthens safety documentation and supports reliable clinical oversight.